Approved Formulary
QR Code Add Formweb to your mobile device
Approved Formulary
Search results for:

upadacitinib

upadacitinib
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-formulary Interchange
Rinvoq TABLET, EXTENDED RELEASE 45 mg      


Comments:

Upadacitinib is a RESTRICTED formulary medication.  Use is restricted to patients > 12 yo and > 40 kg who have failed indicated medication therapy and are only left with surgical intervention treatment options for IBD. Must be able to swallow tablet whole.  Medication will not be routinely stocked and will only be procured pursuant to active orders on patient who meets above restriction.  All other use requires approval by Pharmacy Leadership.


Last updated: May. 1, 2024


Lexicomp Online Search
Pharmacy Phone Numbers:
Inpatient Pharmacy: 205-638-9641
IV Room: 205-638-9716
Pharmacy Offices: 205-638-9718

This site is intended for Children's Health System health professionals and employees only.
Use by pharmaceutical/medical representatives or non-CHS personnel is strictly prohibited.